Binding Mechanism between Platelet Glycoprotein and Cyclic Peptide Elucidated by McMD-Based Dynamic Docking

Area of Science:

• Biochemistry
• Molecular Biology
• Computational Chemistry

Background:

• Platelet aggregation is mediated by the interaction between platelet glycoprotein Ibα (GPIbα) and von Willebrand factor (vWF).
• The cyclic peptide OS1 inhibits this interaction by binding to GPIbα, but its precise binding mechanism and inhibition strategy remain unclear.

Purpose of the Study:

• To elucidate the binding mechanism between OS1 and GPIbα using computational methods.
• To understand how OS1 binding inhibits the GPIbα-vWF complex formation.

Main Methods:

• Multicanonical molecular dynamics (McMD)-based dynamic docking protocol was employed.
• Simulations were initiated from the unbound state of OS1 and GPIbα.

Main Results:

• The simulation successfully reproduced the experimental complex structure of OS1-GPIbα.
• An intermediate binding conformation was identified where OS1 bound to the same site but with a different GPIbα β-switch conformation.
• Subsequent refolding of the β-switch led to a more stable binding configuration, though this transition takes time.
• Allosteric binding sites on GPIbα that could also affect vWF binding were identified.

Conclusions:

• Conformational changes in the GPIbα β-switch are critical for stable OS1 binding and effective inhibition.
• Targeting identified allosteric sites on GPIbα could lead to novel, more potent inhibitors independent of β-switch conformation.